TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial.

Philippe Armand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.